Notably, in an SMA mouse model, the muscle‐specific SMN reduction has been described to transition to a cell‐autonomous muscle pathology as a consequence of ongoing low SMN levels.32 This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.